Rare cases of postoperative liver necrosis have occurred following general anaesthesia since its origin in 1846. While certain agents such as chloroform and halothane have definitely been shown to cause liver necrosis in the clinical situation, the hepatotoxic potential of enflurane remains controversial. When liver dysfunction occurs after surgery, it can be difficult to differentiate the role of volatile anaesthetic agents from other aetiological factors. The following case history suggests a possible role of both enflurane and cardiopulmonary bypass in the development of hepatic necrosis.
CASE HISTORY
A 66-year-old 45 kg female was admitted to hospital with chest pain. Her past history included non-insulin dependent diabetes mellitus controlled with gliclazide and metformin. She had undergone a minor surgical procedure on her thumb, under general anaesthesia, 15 years previously (anaesthetic record unavailable). Three weeks prior to admission she developed exertional chest pain which was initially controlled with isosorbide dinitrate and metoprolol. Despite maximum medical therapy in hospital (nifedipine, metoprolol, isosorbide dinitrate, aspirin, heparin infusion), her pain did not settle, although there was no evidence of myocardial infarction. Cardiac catheterization was performed, and demonstrated two vessel coronary artery disease with mild hypokinesis of the posterobasal segment of the left ventricle. The patient was referred for coronary artery bypass grafting.
Premedication consisted of lorazepam 3 mg. Anaesthesia was induced with fentanyl 0.75 mg and midazolam 3 mg. Following administration of pancuronium, she was intubated and ventilated with nitrous oxide 50% in oxygen 50% and enflurane < 2%.
Cephalothin 2 g was given as antibiotic prophylaxis. Other drugs administered included infusions of glyceryl trinitrate and low-dose dopamine. Soluble insulin infusion was administered for blood glucose control. Intraoperative monitoring consisted of electrocardiogram (5-lead), direct radial artery pressure, central venous and pulmonary arterial pressures, pulse oximetry and capnography.
The pre-bypass period was uneventful, with the patient remaining haemodynamically stable. Cardiopulmonary bypass was established using a Sarns 8000 roller pump (MMM, Thornleigh, NSW) and Dideco membrane oxygenator (Sorin, Lane Cove, NSW). Nonpulsatile flow was used, with flow rates of 2.5l1min/m 2 at normothermia and 1.5 lImin/m 2 at hypothermia at a nasopharangeal temperature of 28 QC. Anaesthesia during bypass was maintained with enflurane 2070 during normothermia and rewarming, and 0.4% during hypothermia. Blood glucose increased to 14 mmolll during bypass and was controlled with insulin. Mixed venous saturation was monitored and remained greater than 75%. Two units of blood were transfused to maintain a haemoglobin concentration of > 6.0 gldl.
Bypass was otherwise uneventful. The bypass time was 75 minutes and aortic cross-clamp time 44 minutes. Separation from cardiopulmonary bypass was achieved without difficulty, and the patient transferred to the Intensive Care Unit (ICU). Hypertension during the stay in ICU was treated with glyceryl trinitrate and nifedipine. The initial postoperative course was otherwise uneventful and she was transferred to the ward the following day.
On the third postoperative morning, the patient was noted to be drowsy. During the course of the day she became unrousable, hypotensive and hypothermic. She was readmitted to the ICU where initial investigations demonstrated a profound lactic acidosis (pH 6.7, base excess = -27, lactate 26 mmolll), and hypoglycaemia (blood glucose 2.9 mmolll). The aspartate aminotransferase (AST) at this time was 2327 U/I. Although liver function tests had not been requested on the second postoperative day, serum collected for other investigations was available for retrospective analysis (AST 505 U/I). Liver function tests were normal pre-operatively as well as on the first postoperative day (Table 1) . Serology for Cytomegalovirus and for Hepatitis A, Band C was negative. Intensive care management of this patient included ventilation, circulatory support with inotropic agents and intra-aortic balloon pump. Acute renal failure was treated with continuous venovenous haemodiafiltration. Despite aggressive management, she died on the fifth postoperative day.
Significant autopsy findings were in the liver. There was massive, widespread Zone 3 necrosis (cent rilobular), with necrosis of Zone 2 of the acini in some areas. A thin rim of peri-portal viable parenchyma was evident around most portal tracts. There was minimal inflammation within portal tracts. The coronary artery bypass grafts appeared patent. There was no evidence of recent myocardial infarction.
DISCUSSION
This patient developed fatal hepatic necrosis following routine cardiac surgery performed under enflurane anaesthesia. The histological features were characteristic of the necrosis produced by halogenated anaesthetics. The potential for enflurane to produce hepatic injury is a controversial issue. There have been a number of case reports describing "enflurane hepatitis" since the anaesthetic was first released twenty years ago'-], but there has not been strong evidence identifying a causal relationship. Jaundice following cardiopulmonary bypass is not uncommon 4 but fulminant hepatic necrosis has been rarely reported. In the patient described, the possibility that the combination of enflurane and cardiopulmonary bypass contributed to the hepatic injury must be considered. Lewis et a)5 reviewed 58 cases of presumed enflurane hepatitis and concluded that a syndrome of enflurane associated hepatic necrosis, while very rare, did exist. An idiosyncratic mechanism was proposed. Eger et al 6 challenged these findings. They questioned the role of enflurane as a hepatotoxin, because the proposed mechanism of hepatic injury was based on the halothane model. They argued that this would be unlikely in view of the minimum degree of metabolism of enflurane compared with halothane and the lack of reductive metabolism and free radicle production. However, it is now known that in patients with fulminant hepatic failure associated with halothane, antibodies are not directed against a reductive metabolite of halothane but against the oxidative metabolite trifluoroacetyl halide incorporated onto the hepatocyte'. Recent experimental work by Christ et aP has shown that antibodies detected in the serum of patients with halothane-induced hepatic necrosis also recognize rat liver microsomal proteins covalently altered by the reactive acyl metabolite of enflurane. Thus there is a possible molecular mechanism whereby enflurane may produce hepatic injury. The same workers also looked at whether two hours of clinical anaesthesia with enflurane could produce covalently bound liver adducts, but were unable to demonstrate antigen formation in human liver. This patient was exposed to approximately six hours of enflurane, receiving a considerably greater dose of volatile agent. In addition, the levels of hepatic antigens might be increased in patients exposed to agents that increase the oxidative metabolism of enflurane by cytochrome P450. Experimentally, the induction of diabetes mellitus (present in this patient) enhances the defluoronation of enflurane by inducing cytochrome P450·. Thus there is evidence to suggest that a mechanism similar to halothane hepatoxicity may exist for enflurane.
The combination of decreased hepatic artery blood flow and halothane anaesthesia has been shown to produce liver damage'o. Is it possible that cardiopulmonary bypass, by a similar mechanism, could increase the susceptability to enflurane induced liver damage? Mathie" et al demonstrated a significantly decreased total liver blood flow in dogs undergoing non-pulsatile cardiopulmonary bypass at normothermia. This has also been demonstrated in humans12. A decrease in liver blood flow is the mechanism of injury in the condition of ischaemic hepatitis'3. This condition is usually described in patients with cardiac disease where the striking feature is a pronounced rise in AST. The histological feature is centrilobular necrosis, similar to the picture produced by halogenated anaesthetics. The liver is also subject to other insults during cardiopulmonary bypass which might add to the insult of ischaemic or drug induced injury. Gut ischaemia associated with a decrease in neurosal blood flow has been demonstrated l4. Recent work indicates that intestinal ischaemia/reperfusion injury produces a neutrophil mediated liver injury despite sustained oxygen consumption's.
Cardiopulmonary bypass per se has an adverse effect on liver function. The arterial ketone body ratio (an index of mitochondrial redox potential) has been used Anaesthesia and Intensive Care, Vol. 23, No. 2, April, 1995 to investigate altered hepatic function during and after cardiopulmonary bypass l6 • Cardiopulmonary bypass has a detrimental effect on liver function of most patients assessed by this method.
The differential diagnosis of postoperative hepatic injury may be difficult. Other possible causes in a case such as this need to be excluded. Viral hepatitis is the most common cause of fulminant hepatic failure. There was no serologic evidence of viral infection in this patient. While certain antibiotics such as sulphonamides and erythromycin can produce cholestatic jaundice, cephalothin has not been reported to cause liver damage.
In summary, while a molecular mechanism for "enflurane hepatitis" exists, there is no definite evidence that enflurane on its own can induce liver necrosis in the clinical situation. It is likely that in this case the combination of enflurane and the adverse effects of cardiopulmonary bypass on the liver resulted in fatal hepatic necrosis.
Liver transplantation offers the best chance of survival in patients with fulminant hepatic failure' 7. However, the combination of multiple organ failure and the very rapid clinical deterioration precluded this form of treatment in this patient.
